PS
Proteome Sciences PLC Stock: price and insider trades · United Kingdom
No insider purchase over the last 90 days. The latest, by Martin Diggle, was filed 26 Apr 2022.
Proteome Sciences PLC: what insiders have been doing
Proteome Sciences PLC is a listed company. Filings by its managers are published through RNS (LSE). No insider at Proteome Sciences PLC has published a filing in the past twelve months. The most recent one dates from 26 April 2022.
Since 2014, the database holds 28 purchases and no sales by insiders of the company.
Every figure here comes from the filings published by RNS (LSE) and describes the past, not future prices; it is not investment advice.
Insider Decl.
28
Thresholds
n/a
Buy Volume
€914,178
28 ops. · all time
Sell Volume
n/a
n/a
Since the insiders bought
- +1.6%Entry £0.04 · Close at T+365 £0.04
- -39.9%Entry £0.07 · Close at T+365 £0.04
- -17.4%Entry £0.05 · Close at T+365 £0.04
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 26,454 of 26,913 companies
8.9
score / 100
Value16
Quality2
FCF yld-3.0%
Earn yld-63%
EV/EBITDA·
ROE·
Gross mgn-2.2%
Net mgn-81%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
£0.01
Analyst consensus
Income statement
Revenue£3.8M
Gross profit-£81k-2% margin
EBITDA-£1.7M-46% margin
Net income-£3.1M-61.5% margin
Valuation
Beta0.21
Balance sheet & cash
Market cap£4.8M
Total debt£15.8M
Free Cash Flow-£143k
Profitability & ownership
ROA-17.8%
% insiders18.5%
% institutions24.8%
Last declaration on 26 April 2022
Declarations28 total
- 183,812 shares@ £0.041.9% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:4349550Canonical exit: 21 Jul 2022 (T+90)
- 1,465,000 shares@ £0.0415.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:4344977Canonical exit: 18 Jul 2022 (T+90)
- 900,000 shares@ £0.0531.6% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3947817Canonical exit: 15 Jul 2021 (T+90)
- 625,000 shares@ £0.0514100.0% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3943076Canonical exit: 12 Jul 2021 (T+90)
- 363,037 shares@ £0.03963.4% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3717157Canonical exit: 13 Dec 2020 (T+90)
- 99,999 shares@ £0.03938.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3649245Canonical exit: 1 Oct 2020 (T+90)
- 160,000 shares@ £0.03961.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:3645372Canonical exit: 29 Sept 2020 (T+90)
- 256,424 shares@ £0.0344.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20200303070009_3512956_20200331164955746_2001Canonical exit: 28 May 2020 (T+90)
- 1,000,000 shares@ £0.031611.4% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181126163814_13880782_20200330111438044_5885Canonical exit: 21 Feb 2019 (T+90)
- 500,000 shares@ £0.03245.8% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181123132617_13878856_20200330111438120_7497Canonical exit: 20 Feb 2019 (T+90)
- 500,000 shares@ £0.03426.1% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181121094134_13875381_20200330111438257_10340Canonical exit: 17 Feb 2019 (T+90)
- 500,000 shares@ £0.03426.1% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181116143517_13870557_20200330111438444_14310Canonical exit: 14 Feb 2019 (T+90)
- 1,000,000 shares@ £0.03512.7% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181114121028_13866944_20200330111438581_17202Canonical exit: 10 Feb 2019 (T+90)
- 313,957 shares@ £0.03493.5% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181109163423_13862300_20200330111438771_21170Canonical exit: 6 Feb 2019 (T+90)
- 208,790 shares@ £0.03662.4% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181012164341_13827642_20200330111443320_16375Canonical exit: 7 Jan 2019 (T+90)
- 514,899 shares@ £0.0365.8% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181009152839_13822199_20200330111443495_20137Canonical exit: 3 Jan 2019 (T+90)
- 20,000 shares@ £0.0360.2% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20181004134247_13816953_20200330111443660_23671Canonical exit: 31 Dec 2018 (T+90)
- 75,520 shares@ £0.0361.0% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180921171028_13800812_20200330111446611_6837Canonical exit: 20 Dec 2018 (T+90)
- 601,582 shares@ £0.0367.7% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180912161840_13788658_20200330111446967_14419Canonical exit: 11 Dec 2018 (T+90)
- 469,866 shares@ £0.0366.0% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180907154327_13783579_20200330111447130_17889Canonical exit: 6 Dec 2018 (T+90)
- 500,000 shares@ £0.0356.2% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180814100332_13754677_20200330111404112_13344Canonical exit: 11 Nov 2018 (T+90)
- 1,400,000 shares@ £0.03517.4% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180809132350_13750194_20200330111404398_16046Canonical exit: 5 Nov 2018 (T+90)
- 328,000 shares@ £0.0354.1% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180802100319_13741434_20200330111404821_21386Canonical exit: 30 Oct 2018 (T+90)
- 643,000 shares@ £0.0358.1% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180731160944_13738368_20200330111419816_196Canonical exit: 25 Oct 2018 (T+90)
- 171,000 shares@ £0.02851.7% of flowLondon Stock Exchange, AIM (XLON)ISIN GB0003104196FCA-NSM:LSE20180727122155_13734472_20200330111419934_2685Canonical exit: 23 Oct 2018 (T+90)
25 of 28 declarations
About Proteome Sciences PLC
Proteome Sciences PLC is a company specializing in proteomics and biomarker research, providing research and development services for applications in health and life sciences.
